Presented by:
Sheldon Brown, MD
Kathleen Burns, MD
Maanasi Chandarana, DO
Eric Downes, MD
Brett Flanagan, MD
Jerett Watnick, DO
Faculty Disclosure:
Drs Sheldon Brown, Kathleen Burns, Maanasi Chandarana, Eric Downes, Brett Flanagan, and Jerett Watnick have disclosed that they have no relevant financial relationships to disclose. No one else in a position to control content has any financial relationships to disclose.
Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/.
Release Date: September 26, 2020
Expiration Date: September 25, 2023
Target Audience: Primary Care Physicians
Learning Objectives:
As a result of participation in this activity, participants should be able to:
· Recognize the difference between THC and CBD.
· Identify the various types of CBD products currently on the market.
· Review and describe the laws for cannabis in the US.
· Recognize and identify applications of CBD.
Requirements for successful completion: Certificates are awarded upon successful completion (80% proficiency) of the post-test.
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Resource(s) for further study:
- https://druglibrary.org/schaffer/hemp/history/first12000/abel.htm
- https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms
If you have any questions please feel free to contact Martha Pennock Schaub at (352) 294-4918 or at marpen@ufl.edu
Section #s: 1368, 2144, 3015